Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Core and Main Inc (CNM) vs Hims and Hers Health Inc (HIMS) Price & Performance

Core and Main IncTrade
Hims and Hers Health IncTrade

Price performance (Past 24H)

Key statistics

Core and Main Inc vs Hims and Hers Health Inc — how do they compare? Core and Main Inc trades at $44.63 (market cap $8.46B), while Hims and Hers Health Inc trades at $36.51 (market cap $8.14B). The key difference: Core and Main Inc and Hims and Hers Health Inc are close in size by market cap, and Hims and Hers Health Inc is trading nearer its 52-week high, Core and Main Inc nearer its low. Which is the better fit depends on your goals.

CNMHIMS
Market Cap
$8.46B$8.14B
Sector
TechnologyHealth
52-Week High
$66.98$66.18
52-Week Low
$44.29$14.52
Enterprise Value
$10.76B$8.52B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Core and Main Inc

Core & Main (CNM) trades at $44.74, down 2.44% today, amid bearish technical signals but strong fundamentals. The stock shows consistent earnings beats, with Q1 2026 EPS of $0.72 exceeding expectations, and maintains solid profitability with a 23.73% ROE. Recent news highlights municipal strength and margin gains, though residential segments face weakness. Cash flow trends improved in 2026 projections, with net cash flow rising to $142M from $7M in 2025.

The outlook is mixed: analyst consensus leans bullish with 57% buy ratings, but technical indicators signal near-term pressure. Key risks include industry headwinds like high operating costs and residential market softness. Investors should weigh strong fundamentals against current bearish momentum for entry timing.

Hims and Hers Health Inc

Hims & Hers Health trades at $34.38, showing no change in the last session. The stock exhibits a bullish technical setup with moving averages supporting upward momentum, while oscillators remain neutral. Recent earnings have been mixed, with Q1 2026 missing expectations, but revenue growth remains positive. Analyst sentiment is divided with a 35% buy rating, and the consensus price target is $33.57. News highlights include expansion in weight-loss treatments and a new JPMorgan receivables facility.

The outlook for HIMS is cautiously optimistic, driven by growth in telehealth and weight-loss segments, but high valuation multiples and recent net income declines pose risks. Investment opportunity lies in market expansion and subscriber growth, while execution risks and competitive pressures require monitoring.

Returns comparison

Trailing returns across standard periods

About Core and Main Inc

Core & Main is a leading US distributor of water, wastewater, storm drainage, and fire protection products. It provides essential infrastructure solutions to municipalities, private water companies, and contractors.

Read more on CNM

About Hims and Hers Health Inc

Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.

Read more on HIMS